» The Role of the Nurse in nmCRPC Patient Management

In this video, Research Nurse Coordinator Pablo Peinado discusses selecting treatments for nmCRPC in clinical practice to minimise the impact on the patient's quality of life, and how nurses can support and educate their patients, so they know what to expect during treatment.

Clinical Takeaways

Patients with nmCRPC are generally asymptomatic and are often older with chronic comorbidities requiring long-term concomitant medication
Risk-benefit analysis usually favours initiating treatment with second-generation ARIs, even in older patients
Individualised treatment decision-making is important and should take into consideration comorbidities and potential drug-drug interactions, in addition to tolerability and safety profiles
The nurse has a pivotal role in the management of nmCRPC patients

This educational programme is endorsed by

Pablo Peinado is a Senior Research Nurse Coordinator at Hospital Universitario Virgen de la Victoria in Malaga, Spain. Pablo gained his Nursing Degree at the University of Valencia in 2014 and moved to the UK where he worked as a surgical nurse for two years. In 2016 he received his Clinical Trials master’s degree and started to work as a Haematology Research Nurse at Churchill Hospital, Oxford where he was in charge of conducting different clinical trials for haematology patients. Pablo moved back to Spain in 2017 to be part of a new GU tumour unit under Dr David Olmos at Hospital Virgen de la Victoria, Malaga and worked as an Oncology Research Nurse with GU patients diagnosed with prostate, bladder and kidney cancer, coordinating early and late phase clinical trials. He has recently been promoted to lead a new Clinical Research Unit and is in charge of coordinating a unit where the objectives are to treat patients with the most advanced medications and provide a personalised approach to their disease so that they can participate more actively during their treatment, learning about their disease and understanding the process of their treatment.